Senior insider sale
Corporate Controller at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$387.9K
25.11K shares
What this filing means
PISKEL KYLE plans to sell 25.11K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $387.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/16/2026ACC: 0001780662-26-000008
Officer· Corporate Controller
Since Jun 2019
25.11K
Shares to sell
$387.9K
Approx. market value
18.67K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
3/10/2026
18.67KTotal acquired18.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/10/2026 | Restricted Stock Units N/A | 18.67K | — |
| Total | 18.67K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
2.15K
Market value
$39.6K
2/4/2026
—Completed
Units to sell
4.29K
Market value
$77.2K
1/12/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
18.67K
Market value
$271.1K
3/11/2026
Total
Units
25.11K
Value
$387.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/4/2026 | 2.15K | $39.6K | — | Completed |
1/12/2026 | 4.29K | $77.2K | — | Completed |
| Planned — Approximate Date | ||||
3/11/2026 | 18.67K | $271.1K | NASDAQ | Planned |
| Total | 25.11K | $387.9K | ||